Effect of Autologous Cord Blood Mononuclear Cells for Digestive System in Preterm Neonates
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Pre-clinical animal studies provide robust evidence regarding the beneficial effect of stem
cells for intestinal disease.
This single-center, randomized, controlled, blinded trial assessed the effect of a single
intravenous infusion of autologous cord blood MNCs (ACBMNCs) in preventing NEC in preterm
neonates,and influence on growth and development.